会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Therapeutic compositions with a cytostatic action containing isocyanuric
acid derivatives and process of manufacture
    • 含有异氰脲酸衍生物的细胞生长抑制作用的治疗组合物及其制造方法
    • US4376120A
    • 1983-03-08
    • US289392
    • 1981-08-03
    • Ulrich ZeidlerHerbert FischerBrigitte HaseHinrich MollerHans-Christoph Wilk
    • Ulrich ZeidlerHerbert FischerBrigitte HaseHinrich MollerHans-Christoph Wilk
    • C07D251/34A61K31/53
    • C07D251/34
    • New cytostatic compounds based on isocyanuric acid derivatives having 2 or 3 epoxide group containing substituents on ring nitrogen atoms, of which at least one differs from a glycidyl, having the formula ##STR1## wherein Oxiranyl is the same or different and has the formula ##STR2## wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different and members selected from the group consisting of hydrogen, alkyl, haloalkyl, hydroxyalkyl and alkoxyalkyl and n in an integer from 1 to 8, with the proviso that if n is 1 in all oxiranyl groups, at least one of R.sub.1 or R.sub.3 is other than hydrogen, and R is a member selected from the group consisting of oxiranyl as defined above, hydrogen, alkyl, alkenyl, hydrocarbon aryl, hydrocarbon aralkyl, hydrocarbon alkaryl, cycloalkyl, and cycloalkenyl, optionally containing substituents.When R.sub.1, R.sub.2 and/or R.sub.3 denote alkyl or substituted alkyl in the oxiranyl radical, the alkyl radicals preferably have from 1 to 4 carbon atoms. The total number of carbon atoms in one oxiranyl radical should not be more than 10. The preparation of these compounds by introducing oxiranyl groups of Formula II and the radical R in known manner into the isocyanuric acid ring is also claimed.
    • 基于在环氮原子上具有2或3个环氧基团的取代基的异氰脲酸衍生物的新的细胞抑制化合物,其中至少一个不同于缩水甘油基,其具有式(VII),其中环氧乙烷基相同或不同,具有式IMA图 其中R 1,R 2和R 3相同或不同,并且选自氢,烷基,卤代烷基,羟基烷基和烷氧基烷基和n在1至8的整数中的成员,条件是如果在所有环氧乙烷基中n为1 基团,R 1或R 3中的至少一个不是氢,R是选自如上定义的环氧乙烷,氢,烷基,烯基,烃芳基,烃芳烷基,烃烷芳基,环烷基和环烯基的成员, 任选地含有取代基。 当R1,R2和/或R3表示环氧乙烷基中的烷基或取代的烷基时,烷基优选具有1至4个碳原子。 一个环氧乙烷基中碳原子的总数不应大于10.通过将式II的环氧乙烷基和已知方式的基团R引入到异氰脲酸环中,这些化合物的制备也被要求保护。
    • 7. 发明授权
    • Amphoteric and zwitter-ionic phosphate surfactants
    • 两性和两性离子磷酸盐表面活性剂
    • US4824603A
    • 1989-04-25
    • US115003
    • 1987-10-28
    • Hinrich MollerUlrich Zeidler
    • Hinrich MollerUlrich Zeidler
    • A61K8/55A61Q5/02A61Q19/10B01F17/14B01F17/18C07F9/09C07F9/40C11D1/88C11D1/62C11D1/94
    • C11D1/886A61K8/55A61Q19/10A61Q5/02C07F9/091
    • Amphoteric and zwitter-ionic phosphate surfactants corresponding to the following formula ##STR1## (a) in which R.sup.1 is a C.sub.6 -C.sub.22 alkyl group, a group R.sup.4 (OC.sub.n H.sub.2n).sub.x --, where n=2 to 4, x=1 to 6, and R.sup.4 is a C.sub.6 -C.sub.22 alkyl group, or a group R.sup.5 --CONH(CH.sub.2).sub.m, where R.sup.5 is a C.sub.5 -C.sub.21 group and m=2 to 4; R.sup.2 is hydrogen; and R.sup.3 is a C.sub.1 -C.sub.4 alkyl group or a group --(C.sub.n H.sub.2n O).sub.x --H or --(C.sub.n H.sub.2n O).sub.x --PO.sub.3 H.sub.2, where n=2 to 4 and x=1 to 6, or(b) in which R.sup.1 is a C.sub.1 -C.sub.4 alkyl group or a C.sub.2 -C.sub.4 2-hydroxyalkyl group; R.sup.2 is a C.sub.6 -C.sub.22 alkyl group; and R.sup.3 is as defined above.to mixtures thereof with correspondingly substituted phosphate surfactants corresponding to formula (I), in which the --PO.sub.3 H.sub.2 group or groups are replaced by hydrogen; and to neutral and basic salts of the foregoing. The invention also relates to processes for the manufacture of the above surfactants, and to their use as skin-compatible washing-active components in body shampoos and hair shampoos.
    • 对应于下列式(Ⅰ)(a)的两性和两性离子型磷酸酯表面活性剂,其中R 1为C 6 -C 22烷基,R 4(OC n H 2n)x - ,其中n = 2至4,x = 1〜6,R4为C6〜C22烷基,R5〜CONH(CH2)m基,R5为C5-C21基,m = 2〜4; R2是氢; R3为C1-C4烷基或 - (CnH2nO)xH或 - (CnH2nO)x-PO3H2,其中n = 2〜4,x = 1〜6,或(b)其中R1为C1- C4烷基或C2-C42-羟烷基; R2是C6-C22烷基; 并且R 3如上所定义。 与对应于式(I)的相应取代的磷酸盐表面活性剂的混合物,其中-PO 3 H 2基团被氢取代; 以及前述的中性和碱性盐。 本发明还涉及制造上述表面活性剂的方法,以及它们在人体洗发剂和洗发剂中作为皮肤相容的洗涤活性成分的用途。